Lipids in Health and Disease

Scope & Guideline

Transforming lipid research into actionable health solutions.

Introduction

Delve into the academic richness of Lipids in Health and Disease with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationLIPIDS HEALTH DIS / Lipids Health Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Lipids in Health and Disease' aims to advance the understanding of lipid metabolism and its implications for health and disease. It publishes research on various aspects of lipid biology, including the role of lipids in metabolic diseases, cardiovascular health, and other related conditions.
  1. Lipid Metabolism and Disease:
    The journal focuses on the relationship between lipid metabolism and various diseases, particularly metabolic syndrome, cardiovascular diseases, and liver conditions. It seeks to uncover the mechanisms by which lipid dysregulation contributes to disease pathogenesis.
  2. Epidemiological Studies:
    There is a strong emphasis on population-based studies that explore the associations between lipid levels, dietary intake, and health outcomes. This includes cross-sectional studies, cohort analyses, and systematic reviews that provide insights into lipid-related health risks in different populations.
  3. Molecular Mechanisms of Lipid Action:
    Research that delves into the molecular and cellular mechanisms by which lipids influence health is a core area of focus. This includes studies on lipid signaling pathways, gene expression related to lipid metabolism, and the impact of lipids on cellular functions.
  4. Clinical Interventions and Therapies:
    The journal also publishes studies on clinical interventions aimed at modifying lipid levels, such as dietary changes, pharmacological treatments, and lifestyle modifications. It evaluates the efficacy and safety of these interventions in managing lipid-related disorders.
  5. Innovative Methodologies:
    Utilizing cutting-edge methodologies, including machine learning and advanced lipidomic techniques, the journal highlights novel approaches to studying lipid metabolism and its clinical implications.
Recent publications in 'Lipids in Health and Disease' indicate a shift towards emerging themes that reflect current societal health challenges and advances in research methodologies. These trends highlight the journal's responsiveness to evolving scientific inquiries.
  1. Integration of Lipids and Inflammation:
    There is an increasing focus on the relationship between lipid metabolism and inflammation, particularly how lipid profiles can influence inflammatory pathways in various diseases, including metabolic syndrome and cardiovascular diseases.
  2. Lipidomics and Precision Medicine:
    The application of lipidomics in precision medicine is gaining traction. Research is increasingly looking at how individual lipid profiles can inform personalized treatment strategies for conditions like diabetes and cardiovascular diseases.
  3. Impact of Lifestyle Factors on Lipid Profiles:
    Studies examining the effects of lifestyle interventions, such as diet, exercise, and sleep, on lipid profiles are trending. This reflects a growing interest in holistic and preventive approaches to managing lipid-related health issues.
  4. Mendelian Randomization Studies:
    The use of Mendelian randomization to infer causality between lipid levels and health outcomes is becoming more prevalent, providing robust evidence for the role of lipids in various diseases.
  5. Longitudinal Studies on Lipid Dynamics:
    Emerging research is increasingly longitudinal, exploring changes in lipid profiles over time and their implications for long-term health outcomes, particularly in aging populations.

Declining or Waning

While 'Lipids in Health and Disease' continually evolves, some areas of research have shown a decline in publication frequency, suggesting a potential waning interest or saturation of studies in those specific themes.
  1. Basic Lipid Chemistry:
    Research focused solely on basic lipid chemistry without direct implications for health or disease has seen a decline. The journal has shifted towards studies that connect lipid chemistry with clinical outcomes or disease mechanisms.
  2. Animal Models without Clinical Correlation:
    Papers primarily using animal models to study lipid metabolism without translating findings to human health or clinical relevance have decreased. The trend is towards studies that can bridge animal research with human applications.
  3. Single-Disease Focus:
    There is a noticeable decrease in studies focusing exclusively on a single disease, such as isolated cardiovascular diseases. The journal now favors research that considers the interplay between multiple conditions and their lipid-related aspects.
  4. Overlapping Indices for Lipid Assessment:
    The use of overlapping or redundant lipid indices for assessing cardiovascular risk has diminished, as the field moves towards more standardized and clinically relevant measures.
  5. Traditional Epidemiological Approaches:
    More traditional epidemiological approaches that lack innovative analytical methods or fail to incorporate modern statistical techniques are less common, as the journal embraces more sophisticated methodologies.

Similar Journals

Journal of Clinical Lipidology

Transforming understanding in lipidology and its clinical applications.
Publisher: ELSEVIER SCIENCE INCISSN: 1933-2874Frequency: 6 issues/year

Journal of Clinical Lipidology, published by Elsevier Science Inc, is a leading platform dedicated to advancing the understanding of lipidology and its impact on cardiovascular health. With an ISSN of 1933-2874 and E-ISSN 1876-4789, this esteemed journal boasts a remarkable Q1 ranking in key medical categories, including Cardiology and Cardiovascular Medicine, Internal Medicine, and Nutrition and Dietetics, solidifying its position as a vital resource for the latest research and clinical practices. This journal not only serves as a repository for groundbreaking studies but also provides insights into complex interactions between lipid metabolism and chronic diseases, including diabetes and obesity. Researchers, practitioners, and students will find a wealth of carefully vetted articles that drive innovation and improve patient outcomes in lipid management. Although it does not currently offer open access, the Journal of Clinical Lipidology ensures high visibility through rigorous peer review and a commitment to quality, making it an essential read for anyone invested in the future of lipidology.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Bridging the gap between nutrition, metabolism, and cardiovascular care.
Publisher: ELSEVIER SCI LTDISSN: 0939-4753Frequency: 12 issues/year

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, published by Elsevier Science Ltd, is a prestigious academic journal dedicated to advancing the knowledge and understanding of the intricate relationships between nutrition, metabolism, and cardiovascular health. With an impressive HIndex and a consistent trajectory of high-impact research, this journal occupies a commendable position in the academic landscape, achieving Q1 rankings in both Cardiology and Cardiovascular Medicine, as well as in Nutrition and Dietetics for the year 2023. The journal’s Scopus rankings further solidify its reputation, occupying top percentiles across various categories, making it an essential resource for researchers, healthcare professionals, and students keen on exploring the latest findings in the field. Although it is not an open access journal, readers can access a wealth of knowledge that spans from 1996 to 2024, with articles that cover diverse topics in endocrinology, diabetes, and metabolism. By disseminating groundbreaking research and reviews, NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES aims to foster innovation and evidence-based practices that contribute to improved health outcomes worldwide.

BIOCHEMICAL JOURNAL

Fostering Innovation in Biochemistry and Beyond
Publisher: PORTLAND PRESS LTDISSN: 0264-6021Frequency: 24 issues/year

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

BIOPHYSICAL CHEMISTRY

Elevating academic discourse in biochemistry and biophysics.
Publisher: ELSEVIERISSN: 0301-4622Frequency: 12 issues/year

BIOPHYSICAL CHEMISTRY, published by Elsevier, is a prestigious journal with a long-standing tradition since its inception in 1973. This highly respected journal focuses on the intersections of biochemistry, biophysics, and organic chemistry, providing a critical platform for researchers, professionals, and students to disseminate pivotal findings in these dynamic fields. With an impressive impact factor that reflects its robust academic influence and high citation rates, it ranks within the Q2 quartile among its peers in multiple categories, indicating its significance in the scholarly community. The journal, hosted in the Netherlands, encompasses a diverse range of topics, from molecular interactions to protein folding, and serves as an essential resource for those engaged in cutting-edge research. Researchers looking to share their work with a global audience will find BIOPHYSICAL CHEMISTRY an invaluable outlet, fostering the advancement of knowledge in this crucial area of science. For more information, visit the journal's page on the Elsevier platform.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Driving excellence in vascular research for a healthier tomorrow.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1079-5642Frequency: 12 issues/year

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, published by Lippincott Williams & Wilkins, is a leading journal in the field of cardiovascular medicine, dedicated to the advancement of research surrounding arterial diseases, thrombosis, and vascular biology. With an impressive impact factor indicative of its reach and influence, this journal occupies a prominent position in the Q1 category of cardiology, ranking 13th out of 387 in its field according to Scopus, placing it within the top 96th percentile among cardiovascular research journals. Since its inception in 1990, ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY has been pivotal in disseminating cutting-edge research that drives innovation and education in cardiovascular health. Although it does not operate under an open access model, the journal is a vital resource for researchers, clinicians, and students looking for high-quality, peer-reviewed articles that contribute to the understanding and treatment of cardiovascular and vascular disorders. Its commitment to rigorous scientific standards and its focus on impactful findings make it an essential publication for anyone dedicated to the field.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Advancing the Frontiers of Lipid Biology
Publisher: ELSEVIERISSN: 1388-1981Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, published by Elsevier, is a leading academic journal that focuses on advancing the field of lipid biology. With an ISSN of 1388-1981 and an E-ISSN of 1879-2618, this journal has established itself as an essential resource for researchers, professionals, and students interested in cell and molecular biology, particularly regarding lipid interactions and functions. The journal boasts an impressive impact factor, standing in the top quartiles of its categories—Q1 in Molecular Biology and Q2 in Cell Biology. As part of the vibrant academic landscape of the Netherlands, it supports both traditional and open access publication models, ensuring that vital research is accessible to a global audience. The converged years from 1998 to 2025 mark its sustained commitment to quality and relevance in the fast-evolving field of lipid research. With a strong ranking in Scopus and a percentile in the 80th range in both Molecular Biology and Cell Biology, this journal continues to be a pivotal platform for scholarly communication and innovation in lipid-related research.

AMERICAN JOURNAL OF CLINICAL NUTRITION

Advancing the frontiers of clinical nutrition.
Publisher: ELSEVIER SCIENCE INCISSN: 0002-9165Frequency: 12 issues/year

The American Journal of Clinical Nutrition, published by Elsevier Science Inc, stands as a premier academic platform dedicated to advancing knowledge in the fields of clinical nutrition and dietary science. With its roots tracing back to 1952, this prestigious journal boasts rigorous peer-reviewed research, providing vital insights and evidence-based findings that cater to the ever-evolving landscape of nutrition and health care. Affiliated with a strong reputation, the journal holds an impressive impact factor and is ranked in the top quartile (Q1) in both Nutrition and Dietetics and Medicine (miscellaneous), underscoring its significance in the academic community. With current Scopus rankings placing it #7 in Nursing and Nutrition and Dietetics and #20 in Medicine, it serves as an essential resource for researchers and practitioners seeking to stay at the forefront of clinical nutritional science. This journal not only disseminates groundbreaking research but also fosters collaborations among scholars, enhancing the clinical implications of nutrition practices globally. Access to the journal may vary, given its non-open access format; however, its contributions remain indispensable to professionals and students alike striving to deepen their understanding of clinical nutrition.

LIPIDS

Exploring the intricate roles of lipids in biology.
Publisher: WILEYISSN: 0024-4201Frequency: 6 issues/year

LIPIDS is a renowned peer-reviewed journal published by Wiley, dedicated to the field of lipid research, encompassing biochemistry, molecular biology, and organic chemistry. With its roots dating back to 1966 and a commitment to advancing knowledge until 2024, this journal serves as a vital platform for sharing significant findings in lipid biochemistry and its applications in health and disease. Although it currently does not offer Open Access options, it maintains a respectable standing with a Q3 ranking in Biochemistry and Organic Chemistry, and a Q4 ranking in Cell Biology based on the 2023 category quartiles. Additionally, its Scopus rankings reflect a solid position within the organic chemistry and biochemistry subfields. Published from Germany, LIPIDS caters to researchers, professionals, and students eager to explore the roles of lipids in biological processes and innovatory applications in various scientific disciplines.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Pioneering Research in Biochemistry and Biophysics
Publisher: ELSEVIERISSN: 0005-2736Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES is a prestigious journal dedicated to advancing the field of biomembrane research, published by Elsevier. With a notable track record since its inception in 1967, this journal operates under the dual ISSN 0005-2736 and E-ISSN 1879-2642, and has firmly established itself within the scientific community by ranking in the top tiers of various disciplines, including Q2 in Biochemistry and Cell Biology, and Q1 in Biophysics as of 2023. Its impressive Scopus rankings further underscore its importance, with a rank of 24 in Biophysics reflecting its strong impact on ongoing research. Although it does not offer open access, the journal provides comprehensive insights and breakthroughs essential for scientists, researchers, and advanced students focused on biophysical and biochemical aspects of membranes. By disseminating pivotal findings, BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES contributes significantly to understanding cellular mechanisms, thereby serving as a vital resource for professionals aiming to explore the complexities of biological membranes.

PROGRESS IN LIPID RESEARCH

Connecting Research and Health Through Lipids
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0163-7827Frequency: 4 issues/year

Progress in Lipid Research, published by Pergamon-Elsevier Science Ltd, is a leading scientific journal dedicated to advancing the understanding of lipid biology and its implications for human health. With an impressive impact factor, it ranks in the Q1 quartile in both Biochemistry and Cell Biology as of 2023, reflecting its vital role in disseminating high-quality research. Covering a wide scope of topics from lipid metabolism to cell signaling pathways, the journal serves as a key resource for researchers, professionals, and students alike, striving to elucidate the complex functions of lipids in various biological systems. With publication converging since 1978 and extending to 2024, Progress in Lipid Research continues to provide innovative insights and foster collaboration within the scientific community, solidifying its reputation as an essential platform for lipid research.